Mobile app support for colorectal cancer patients
the Effect of the Interactive Nurse Support Program, Developed as a Mobile Application, on Patient Outcomes in Colorectal Cancer Patients Receiving Chemotherapy During the Covid-19 Process
NA · Ankara University · NCT05813028
This study is testing a mobile app to see if it can help colorectal cancer patients feel better and manage their symptoms while they go through chemotherapy during the COVID-19 pandemic.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ankara University (other) |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Ankara, Çankaya) |
| Trial ID | NCT05813028 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of an interactive mobile application designed to support colorectal cancer patients undergoing chemotherapy during the COVID-19 pandemic. The application includes modules for COVID-19 information, symptom management, peer discussions, expert consultations, and shared patient experiences. It employs a randomized controlled, single-blind design to assess its effects on patient outcomes such as quality of life, social support, anxiety levels, and symptom management. The research is conducted at the Ankara City Hospital Medical Oncology Department Outpatient Clinics.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 diagnosed with stage 0, 1, or 2 colorectal cancer who are first-time chemotherapy recipients and can effectively use an Android mobile phone.
Not a fit: Patients with metastatic colorectal cancer or those who have previously received chemotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this mobile application could significantly improve the quality of life and emotional well-being of colorectal cancer patients during their treatment.
How similar studies have performed: While similar studies focusing on mobile applications for patient support exist, this specific approach targeting colorectal cancer patients during the COVID-19 pandemic is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Volunteering to participate in research * Be over 18 years old * Being diagnosed with stage 0.1,2 colorectal cancer * Ability to understand and speak Turkish * ECOG performance score of 0.1 or 2 * Being literate * Having a mobile phone with an Android processor and being able to use it effectively * First time receiving chemotherapy Exclusion Criteria: * Presence of a diagnosed psychiatric illness * Having received previous chemotherapy * Diagnosis of metastatic colorectal cancer * ECOG performance score of 3 and 4 * Simultaneous radiation therapy with chemotherapy * Visual, auditory, mental or neurological disability * Taking part in another research that will affect the research results
Where this trial is running
Ankara, Çankaya
- Ankara Bilkent City Hospital — Ankara, Çankaya, Turkey (RECRUITING)
Study contacts
- Study coordinator: burcu ağdemir, res. assis.
- Email: bagdemir@ankara.edu.tr
- Phone: +90 531 402 62 56
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Colorectal Cancer, Nursing, mobile application, nursing, symptom management